Similar Papers

Paper Title
Journal
Date
Author
Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
Nicolaus Kröger ... Michael R Bishop
Biology of Blood and Marrow Transplantation | VOL. 17
Nicolaus Kröger, et. al.Nicolaus Kröger ... Michael R Bishop
01 Nov 2010
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
Darius Sairafi ... Jonas Mattsson
Biology of Blood and Marrow Transplantation | VOL. 16
Darius Sairafi, et. al.Darius Sairafi ... Jonas Mattsson
10 Jun 2010
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation
Lia Minculescu ... Henrik Sengeloev
Blood | VOL. 138
Lia Minculescu, et. al.Lia Minculescu ... Henrik Sengeloev
05 Nov 2021
Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation.
Paul S Martin ... Edwin P Alyea
Haematologica | VOL. 101
Paul S Martin, et. al.Paul S Martin ... Edwin P Alyea
14 Jan 2016
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
Aiming Targeted Drug Development at Rare Pediatric Malignancies
Julia L Glade Bender
Journal of Clinical Oncology | VOL. -
Julia L Glade BenderJulia L Glade Bender
03 Feb 2025
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy in patients with advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma enrolled in the Republic of Korea: KEYNOTE-859.
Sun Young Rha ... Do-Youn Oh
Journal of Clinical Oncology | VOL. 43
Sun Young Rha, et. al.Sun Young Rha ... Do-Youn Oh
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.